Stefan Fröhling
German Cancer Research Center(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)National Center for Tumor Diseases(DE)Institute of Human Genetics(PL)Heidelberg Engineering (Germany)(DE)Prof. Hess Kinderklinik(DE)DKFZ-ZMBH Alliance(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Sarcoma Diagnosis and Treatment, Protein Degradation and Inhibitors, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1(2009)4,112 cited
- → Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis(2005)2,971 cited
- → Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia(2008)1,607 cited
- → Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia(2004)995 cited
- → Activating mutations in ALK provide a therapeutic target in neuroblastoma(2008)888 cited
- → Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm(2002)865 cited